Law360, New York (February 20, 2009, 12:00 AM EST) -- A federal appeals court has agreed to hear an interlocutory appeal of Shire LLC’s patent infringement case against Sandoz Inc. over hyperactivity disorder drug Adderall XR that raises a question of whether a patentee is precluded from relitigating claim construction issues determined in a previous case.
The U.S. Court of Appeals for the Federal Circuit earlier this month granted Sandoz’s bid to appeal a September order by a Colorado district court that refused to give preclusive effect to an earlier claim construction order by another district...
Fed. Circ. Takes On Prior Claim Construction Issue
To view the full article, register now.
Try Law360 FREE for seven days
Already a subscriber? Click here to login
